Leading scientists in the field from around the world come together to address the challenges in the sessions ‘Grand Challenges in Computational Biology’, opened by Josep Huguet
The "Acadèmia de Ciències Mèdiques" (Academy of Medical Sciences) confers the Josep Trueta prize to research on Lafora disease performed by Joan J. Guinovart’s lab
Twenty-three of the most renowned scientists working in the field of metastasis come together in Barcelona, invited by IRB Barcelona and the BBVA Foundation. Among these, Tyler Jacks, Joan Massagué, Josep Baselga and the Nobel Prize winners Michael Bishop and Harold Varmus.
The finding made in the fruit fly may provide clues to address problems such as the proliferation of malignant cells and tumour growth in humans
The IRB Barcelona principal investigator has been appointed to the post by the new Minister of Science and Innovation, Cristina Garmendia.
Experts in systems biology, molecular pharmacology and bioengineering convene in Barcelona, invited by IRB Barcelona and the BBVA Foundation.
Today the “Fundación Científica de la Asociación Española Contra el Cáncer” (AECC)(Scientific Foundation of the Spanish Association Against Cancer) and the Institute for Research in Biomedicine (IRB Barcelona) have signed an agreement through which the Foundation will fund the cancer research project entitled, “Estudio de los mecanismos moleculares de la metástasis del cáncer de mama a pulmón: función y potencial terapéutico de genes supresores de metástasis” (Study of the molecular mechanisms of metastasis of breast cancer to the lung: therapeutic function and potential of metastasis suppressor genes). The signing of this agreement was done in IRB Barcelona...
The study, headed by Joan Massagué in New York, has involved researchers at IRB Barcelona and Hospital Clínic-IDIBAPS.
Researchers at IRB Barcelona have demonstrated that the decrease in Dab1 protein expression caused by the infective action of prions also reduces the production of β-amyloid, a risk factor of Alzheimer’s disease.
Epilepsy, cancer, diabetes and depression are just some examples of the severe diseases associated with mutations in these proteins.